Udihep (Ursodeoxycholic Acid 150mg) 10 tablets in Kenya

UDIHEP Tablets in Kenya are supplied in a pack of 10 tablets, with each tablet containing Ursodeoxycholic Acid 150mg as the active ingredient. Udihep is prescribed for a range of hepatic (liver) disorders, including cirrhosis and gallstones, among other ailments as determined by a physician. The mechanism of action for Udihep involves decreasing the production of cholesterol and, importantly, dissolving existing cholesterol in bile. This medication is available by prescription only.

Unpacking the Formulation: Key Component and its Mechanism

Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid that plays a crucial role in the management of cholestatic liver diseases and gallstones.

• Ursodeoxycholic Acid (150mg):
  • Class: Cholelitholytic Agent / Cholagogue.
  • Mechanism of Action: Ursodeoxycholic acid works through several key mechanisms:
    • Dissolving Gallstones: UDCA is a hydrophilic (water-soluble) bile acid. When administered orally, it becomes the dominant bile acid in the bile acid pool. It acts by reducing cholesterol saturation in bile. This is achieved by decreasing cholesterol synthesis in the liver, inhibiting cholesterol absorption from the intestine, and increasing the conversion of cholesterol into bile acids. Consequently, this leads to the solubilization of cholesterol gallstones, facilitating their gradual dissolution.
    • Protecting Liver Cells: In cholestatic liver diseases (where bile flow is impaired), toxic hydrophobic bile acids accumulate in the liver, causing damage. UDCA, being hydrophilic, replaces these toxic bile acids, thereby protecting liver cells from damage.
    • Immunomodulatory Effects: UDCA has been shown to exert mild immunomodulatory effects, which can be beneficial in certain autoimmune liver diseases by reducing inflammation.
    • Stimulating Bile Flow: It can also promote bile flow, further aiding in the removal of harmful substances from the liver.

Addressing Health Concerns and User Needs

Udihep primarily addresses conditions related to impaired bile flow, cholesterol metabolism issues, and certain liver diseases.

• Gallstone Management: Provides a non-surgical option for dissolving certain types of cholesterol gallstones, particularly small, non-calcified stones.
• Liver Protection: Protects liver cells from the damage caused by accumulated toxic bile acids in cholestatic conditions.
• Symptom Relief: Can alleviate symptoms associated with impaired bile flow, such as itching (pruritus) in cholestatic liver diseases.
• Disease Progression Slowdown: In conditions like Primary Biliary Cholangitis (PBC), it can slow the progression of liver damage.

Identifying Indications for Use

UDIHEP (Ursodeoxycholic Acid 150mg) is a prescription-only medication indicated for:

• Dissolution of cholesterol gallstones: For patients with radiolucent (non-calcified) gallstones in a functioning gallbladder, who prefer non-surgical management or are not suitable for surgery.

• Treatment of Primary Biliary Cholangitis (PBC): To improve liver function tests and delay disease progression in patients with compensated PBC.

• Management of various hepatic disorders: Including some forms of chronic cholestatic liver diseases as determined by a physician.

• Biliary reflux gastritis.

Primary Uses

The primary uses of UDIHEP 150mg include:

• Dissolving cholesterol gallstones to avoid surgical intervention.
• Improving liver function and slowing disease progression in specific cholestatic liver diseases like PBC.
• Protecting hepatocytes (liver cells) from damage caused by bile acid accumulation.
• Managing other physician-prescribed hepatic ailments.

Understanding Potential Side Effects and Critical Precautions

While Ursodeoxycholic Acid is generally well-tolerated, it can cause side effects, and certain precautions are necessary.

Common Side Effects (Generally Mild and often transient)

• Gastrointestinal disturbances: Diarrhea (most common, especially at higher doses), nausea, vomiting, abdominal pain or discomfort, dyspepsia.
• Itching (pruritus): Although UDCA can help reduce pruritus in cholestasis, it can paradoxically worsen it in some individuals, particularly at the start of treatment.
• Hair thinning (alopecia).

Less Common but More Serious Side Effects (Requiring Immediate Medical Attention)

• Severe Diarrhea: If severe and persistent diarrhea occurs, especially in patients with PBC, it may warrant dose reduction or discontinuation, as it can be a sign of intolerance.
• Calcification of Gallstones: In some cases, existing cholesterol gallstones may calcify during UDCA treatment, making them opaque to X-rays and less amenable to dissolution.
• Liver enzyme elevations: Although UDCA generally improves liver function tests, paradoxical elevations can occur, especially in individuals with more advanced liver disease or certain genetic variations. Regular monitoring of liver function tests is crucial.
• Worsening of pre-existing liver disease: Though rare, some patients with severe chronic liver disease might experience worsening symptoms.

Critical Safety Warnings and Precautions for UDIHEP (Ursodeoxycholic Acid)

UDIHEP (Ursodeoxycholic Acid) is a prescription-only medication. Its use MUST be under the strict guidance and supervision of a qualified physician, ideally one experienced in hepatology.

• Gallstone Suitability: UDCA is only effective for radiolucent (non-calcified) cholesterol gallstones that are less than 15-20 mm in diameter, and in patients with a functioning gallbladder. It is ineffective for calcified gallstones, pigment stones, or patients with non-functioning gallbladders. Diagnosis requires imaging (e.g., ultrasound).
• Acute Cholecystitis/Cholangitis: Do not use in patients with acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-enteric fistula.
• Liver Disease Severity: Use with caution in patients with severe, decompensated liver cirrhosis or acute liver inflammation.
• Pregnancy and Breastfeeding:
  • Pregnancy: UDCA should be used during pregnancy only if clearly needed and if the potential benefits outweigh the potential risks to the fetus. There are limited human data, but some studies suggest it may be beneficial for cholestasis of pregnancy.
  • Breastfeeding: It is excreted in breast milk in very small amounts. Use with caution during breastfeeding, and only if benefits justify potential risks.
• Drug Interactions: Inform your doctor about all other medications (prescription, over-the-counter, and herbal supplements) you are taking, especially:
  • Cholestyramine, Colestipol, Antacids containing aluminum hydroxide: These can bind UDCA in the intestine and reduce its absorption, making it less effective. Administer UDCA at least 2 hours before or 4 hours after these medications.
  • Estrogens, Oral Contraceptives, Clofibrate, Gemfibrozil (Fibrates): These can increase cholesterol secretion into bile, potentially counteracting the effects of UDCA on gallstone dissolution.
  • Cyclosporine: UDCA may increase the absorption of cyclosporine. Monitor cyclosporine levels.
  • Dapsone: UDCA may reduce dapsone absorption.
• Monitoring: Regular monitoring of liver function tests (ALT, AST, ALP, bilirubin) is crucial during treatment. For gallstone dissolution, repeat ultrasonography of the gallbladder is recommended every 6-12 months.
• Compliance: Long-term treatment is often required for both gallstone dissolution (can take months to years) and liver disease management.
• Diarrhea Management: If severe diarrhea occurs, the dosage should be reduced. If diarrhea persists, the drug may need to be discontinued.

Recommended Dosage and Administration Guidelines

The dosage of UDIHEP (Ursodeoxycholic Acid) varies significantly based on the specific condition being treated, patient weight, and physician’s assessment. Always follow your doctor’s precise prescription.

• General Administration:
  • Take the tablets orally.
  • Typically taken with food to improve absorption and reduce gastrointestinal upset.
  • Swallow the tablets whole with water.
• Typical Adult Dosages (Examples – Varies by indication):
  • For Cholesterol Gallstone Dissolution:
    • Usually 8-10 mg/kg of body weight per day, given in 2-3 divided doses.
    • For a 70kg person, this could be approximately 560-700mg daily, meaning multiple 150mg tablets.
    • The total daily dose is often taken with the evening meal or at bedtime to maximize cholesterol saturation reduction overnight.
    • Treatment may last from 6 months up to 2 years, with regular ultrasound monitoring every 6-12 months.
  • For Primary Biliary Cholangitis (PBC):
    • Generally 13-15 mg/kg of body weight per day, given in 2-4 divided doses.
    • For a 70kg person, this could be approximately 910-1050mg daily.
• Duration of Treatment:
  • For gallstones, treatment is long-term and continues for at least 3-4 months after radiological disappearance of stones to ensure complete dissolution.
  • For PBC and other chronic liver diseases, treatment is typically long-term, often lifelong.
• Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose.

Price in Kenya (Approximate)

As of Wednesday, July 2, 2025, the approximate price for UDIHEP | Ursodeoxycholic Acid 150MG – 10 TABS in Kenya can range from Ksh 300 to Ksh 600 per pack.

Note: Prices for prescription medications like UDIHEP can vary between different pharmacies, and online platforms in Kenya, depending on factors such as supplier, brand (Udihep is a brand name, generic UDCA may vary), and any prevailing duties or taxes. Therefore, it is advisable to check with specific vendors for the most current pricing.

Conclusion

UDIHEP (Ursodeoxycholic Acid 150mg), supplied as 10 tablets, is a vital prescription medication in Kenya for addressing various hepatic disorders, cirrhosis, and particularly for the dissolution of cholesterol gallstones. Its mechanism of action involves decreasing cholesterol production and dissolving cholesterol in bile, thereby improving liver function and preventing stone formation. As a prescription-only drug, Udihep requires precise medical guidance, especially concerning the type of gallstones it can treat and necessary liver function monitoring. Patients must adhere to prescribed dosages and be aware of potential drug interactions and side effects like diarrhea to ensure safe and effective management of their liver and biliary conditions.